Statistics and Outcomes

Blood and Marrow Transplant Survival Rates

Blood and Marrow Transplantation is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at UPMC Children's Hospital of Pittsburgh is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).

Blood and Bone Marrow Transplant

Outcome Measure

Type

UPMC Children's Hospital
100-Day Survival1 All** 100%

One-Year Non-Relapse Mortality2

All**

3%
One-Year Overall Survival3 All**
94%

** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.

1 Percentage of patients living 100 or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)

2 Percentage of patients who died due to causes other than related to underlying disease

3 Percentage of patients living one or more years following the transplant procedure

Blood and Marrow Transplant Volumes


Transplant Type

2018

Program Inception Through
12/31/2017
Allo Blood and Marrow
Transplants

27

391

Auto

15

245

Total


42

636

Sources: Internal data, Hillman Center for Pediatric Transplantation; Scientific Registry of Transplant Recipients (www.srtr.org), January 2019 release.